Advertisement
The Medicine Maker / Issues / 2026 / June / CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
Advertisement

Recommended

Advertisement

Related Content

Musings from The Power List: Daniel Vitt
Small Molecules Drug Discovery Development & Clinical
Musings from The Power List: Daniel Vitt

August 20, 2026

6 min read

From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development

The Road to Commercial-Scale iPSC Cell Therapy
Cell & Gene Development & Clinical Interviews
The Road to Commercial-Scale iPSC Cell Therapy

August 19, 2026

5 min read

Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?

The Mindset for Success in Biopharma's New Multipolar World
Biopharma Development & Clinical Outsourcing
The Mindset for Success in Biopharma's New Multipolar World

August 18, 2026

10 min read

From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market

Musings from The Power List: John Maher
Cell & Gene Power List Development & Clinical
Musings from The Power List: John Maher

August 14, 2026

4 min read

John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors

Advertisement